Commission Implementing Regulation (EU) 2019/1100 of 27 June 2019 concerning the non-renewal of approval of the active substance desmedipham, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance.)
Preamble 1
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC ( 1 ) , and in particular Article 20(1) and Article 78(2) thereof,
Whereas:
HAS ADOPTED THIS REGULATION:
recital 1recital 1
(1) Commission Directive 2004/58/EC ( 2 ) included desmedipham as an active substance in Annex I to Council Directive 91/414/EEC ( 3 ) .
recital 2recital 2
(2) Active substances included in Annex I to Directive 91/414/EEC are deemed to have been approved under Regulation (EC) No 1107/2009 and are listed in Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 ( 4 ) .
recital 3recital 3
(3) The approval of the active substance desmedipham, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011, expires on 31 July 2020.
recital 4recital 4
(4) An application for the renewal of the approval of desmedipham was submitted in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 ( 5 ) within the time period provided for in that Article.
recital 5recital 5
(5) The applicant submitted the supplementary dossiers required in accordance with Article 6 of Implementing Regulation (EU) No 844/2012. The application was found to be complete by the rapporteur Member State.
recital 6recital 6
(6) The rapporteur Member State prepared a renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the European Food Safety Authority (‘the Authority’) and the Commission on 21 December 2016.
recital 7recital 7
(7) The Authority communicated the renewal assessment report to the applicant and to the Member States for comments and forwarded the comments received to the Commission. The Authority also made the supplementary summary dossier available to the public.
recital 8recital 8
(8) On 10 January 2018, the Authority communicated to the Commission its conclusion ( 6 ) on whether desmedipham can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
recital 9recital 9
(9) The Authority identified specific concerns. In particular, it was not possible to exclude exposure of consumers and/or livestock to residues containing free and/or conjugated aniline (classified as mutagen category 2 and carcinogen category 2) and consumer exposure to residues containing 4-aminophenol (classified as mutagen category 2) via animal commodities. In addition, the Authority concluded that a high long-term risk to mammals was identified for all representative uses, except for insectivorous mammals when the use pattern includes only one application. A high long-term risk for birds was identified for the representative uses in sugar beet/fodder beet, when the use pattern includes two or three applications.
recital 10recital 10
(10) Furthermore, the Authority also concluded that the assessment of endocrine disrupting properties could not be completed based on the available information.
recital 11recital 11
(11) The Commission invited the applicant to submit its comments on the conclusion of the Authority and, in accordance with the third subparagraph of Article 14(1) of Implementing Regulation (EU) No 844/2012, on the draft renewal report. The applicant submitted its comments, which have been carefully examined.
recital 12recital 12
(12) However, despite the arguments put forward by the applicant, the concerns regarding the active substance could not be eliminated.
recital 13recital 13
(13) Consequently, it has not been established with respect to one or more representative uses of at least one plant protection product that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied. It is therefore appropriate not to renew the approval of the active substance desmedipham in accordance with Article 20(1)(b) of that Regulation.
recital 14recital 14
(14) Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.
recital 15recital 15
(15) Member States should be given sufficient time to withdraw authorisations for plant protection products containing desmedipham.
recital 16recital 16
(16) For plant protection products containing desmedipham, where Member States grant any grace period in accordance with Article 46 of Regulation (EC) No 1107/2009, that period should at the latest, expire on 1 July 2020.
recital 17recital 17
(17) Commission Implementing Regulation (EU) 2019/707 ( 7 ) extended the approval period of desmedipham to 31 July 2020 in order to allow the renewal process to be completed before the expiry of the approval of that substance. However, given that a decision on the non-renewal of the approval has been taken ahead of that extended expiry date, this Regulation should apply as soon as possible.
recital 18recital 18
(18) This Regulation does not prevent the submission of a further application for the approval of desmedipham pursuant to Article 7 of Regulation (EC) No 1107/2009.
recital 19recital 19
(19) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
Article 1Non-renewal of the approval of active substance
The approval of the active substance desmedipham is not renewed.
Article 2Amendment to Implementing Regulation (EU) No 540/2011
In Part A of the Annex to Implementing Regulation (EU) No 540/2011, row 86, on desmedipham, is deleted.
Article 3Transitional measures
Member States shall withdraw authorisations for plant protection products containing desmedipham as active substance by 1 January 2020 at the latest.
Article 4Grace period
Any grace period granted by Member States in accordance with Article 46 of Regulation (EC) No 1107/2009 shall expire by 1 July 2020 at the latest.
Article 5Entry into force
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .